Regulation 5 Prohibition on administration of beta-agonists or hormonal substancesI1
England and Wales
Subject to paragraph (2), no person may administer or knowingly cause or permit to be administered to any animal any product which is, or which contains, a substance listed in Annex II or III to Council Directive 96/22.
The prohibition in paragraph (1) does not apply to the administration of a compliant veterinary medicinal product—
containing testosterone, progesterone or a derivative of these substances which readily yields the parent compound on hydrolysis after absorption at the site of application, if the administration is in accordance with regulation 27;
containing allyl trenbolone or a beta-agonist, if the administration is in accordance with regulation 28; or
having oestrogenic action (but not containing oestradiol 17b or its ester-like derivatives), adrogenic action or gestagenic action, if the administration is in accordance with regulation 29.
In paragraph (2), “compliant veterinary medicinal product” means a veterinary medicinal product which complies with the requirements of regulation 26.
Annotations
Commencement
- I1
Reg. 5 in force at 28.3.2019, see reg. 1(3)